SCHEMBL256107

SCHEMBL256107

CC(=O)NC(C)Cc1ccc(C#Cc2ccc(C(=O)NCC3CCCO3)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACACB O00763 19/20 1.00
MEN1 O00255 1/20 0.59
KMT2A Q03164 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12001248 0.91 ACACB (0.83) ACACBMEN1KMT2A
SCHEMBL255731 0.91 ACACB (1.00) ACACB
SCHEMBL256113 0.84 ACACB (1.00) ACACB
SCHEMBL12001265 0.82 ACACB (0.76) ACACBMEN1KMT2A
SCHEMBL24230211 0.81 KMT2A (0.73) ACACBMEN1KMT2A
SCHEMBL256276 0.79 ACACB (1.00) ACACB
SCHEMBL25217118 0.79 KMT2A (0.73) ACACBMEN1KMT2A
SCHEMBL25213967 0.79 KMT2A (0.73) ACACBMEN1KMT2A
SCHEMBL25268096 0.79 KMT2A (0.73) ACACBMEN1KMT2A
SCHEMBL16063362 0.79 ACACB (1.00) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611771-B1 SUBSTITUTED HETEROARYL- AND ARYLALKYNYL BENZENE DERIVATIVES AS ACC-INHIBITORS FOR THE TREATMENT OF METABOLIC DISEASES BOEHRINGER INGELHEIM INT (DE) 2016-11-23 EP disclosed
US-8835472-B2 Compounds, pharmaceutical compositions and uses thereof BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2014-09-16 US disclosed
WO-2012028676-A1 NEW COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-03-08 WO disclosed